Saturday, November 9, 2024

Titan acquires 27.2 pc additional share of CaratLane in Rs 4,621-crore deal

Date:

New Delhi: Branded jewellery maker Titan on Saturday announced the acquisition of an additional 27.18 per cent stake in its subsidiary CaratLane, taking its total holding to 98.28 per cent.

The Tata group-controlled firm entered into a share purchase agreement on Saturday to acquire 91.90 lakh equity shares held by the founder of CaratLane Trading Pvt Ltd and his family members, said a regulatory filing.

“CaratLane is a subsidiary of the company and on completion of the aforesaid share purchase would result in an increase in shareholding of the company in CaratLane from 71.09 per cent to 98.28 per cent on a fully diluted basis,” it said.

Over the cost of the acquisition, Titan said it will pay “Rs 4,621 crore towards the purchase of 27.18 per cent equity shares of CaratLane on a fully diluted basis”.

CaratLane Trading is an unlisted entity and its turnover in FY23 stood at Rs 2,177 crore. It also operates in the manufacture and sale of jewellery.

Titan expects the acquisition to be complete by October 31, 2023, subject to the timely receipt of requisite regulatory approvals from the Competition Commission of India (CCI).

“On acquisition of 27.18 per cent of the shareholding of CaratLane, the company would hold an aggregate of 98.28 per cent of the equity share capital on a fully diluted basis and voting rights in CaratLane,” it said.

CaratLane, which was incorporated in September 2007, also has presence in the United States through its subsidiary.

PTI

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Discover how Chief Justice DY Chandrachud is promoting awareness about myopathy and how the public is connecting vaccine side effects to muscle disorders

A few days ago, Chief Justice DY Chandrachud spoke about his daughters condition, nemaline myopathy, which is a...

Covid Vaccine Victim EXPOSES the System: Participant’s Experience in AstraZeneca’s COVID-19 Vaccine Trial and Post-Vaccine Neuropathy

In this explosive episode, we delve into the story of Brianne Dressen, a participant in the AstraZeneca COVID-19...

Watch India Debate with Ashutosh Pathak on Karan Johar, Yash Johar and Dharma Productions

Latest News: https://qvive.in/india-news/did-vaccine-side-effects-cause-heart-attack-in-singer-kks-sudden-death

Insights from NIH Report: Exploring the Link Between COVID-19 Vaccine Side Effects, Hypoxia, and Heart Attack – Singer KK’s Sudden Death

KK, whose real name was Krishnakumar Kunnath, rose to fame in the early 2000s with his soulful voice...